Prognostic value of twist in lung cancer: Systematic review and meta-analysis

Translational Lung Cancer Research

Volumn 4, Issue 3, 2015, Pages 236-241

  Zeng, Junli ^a   Zhan, Ping ^b   Wu, Guannan ^b   Yang, Wen ^b   Liang, Wenjun ^b   Lv, Tangfeng ^a,b   Song, Yong ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Lung cancer; Poor survival; Prognosis; Twist

Indexed keywords

TRANSCRIPTION FACTOR TWIST;

ARTICLE; CANCER PROGNOSIS; CLINICAL ASSESSMENT; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EMBASE; GENETIC ASSOCIATION; HUMAN; LUNG CANCER; MEDLINE; META ANALYSIS (TOPIC); PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; WEB OF SCIENCE;

EID: 84949640128     PISSN: 22186751     EISSN: 22264477     Source Type: Journal    
DOI: 10.3978/j.issn.2218-6751.2015.04.06     Document Type: Article

References (29)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5-29
2. Hosono S, Kajiyama H, Terauchi M, et al. Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients. Br J Cancer 2007;96:314-20
3. Burotto M, Thomas A, Subramaniam D, et al. Biomarkers in early-stage non-small-cell lung cancer: current concepts and future directions. J Thorac Oncol 2014;9:1609-17
4. D'Amico TA. Molecular biologic staging of lung cancer. Ann Thorac Surg 2008;85:S737-42
5. Thiery JP, Acloque H, Huang RY, et al. Epithelialmesenchymal transitions in development and disease. Cell 2009;139:871-90
6. Nieto MA. Epithelial plasticity: a common theme in embryonic and cancer cells. Science 2013;342:1234850
7. Micalizzi DS, Ford HL. Epithelial-mesenchymal transition in development and cancer. Future Oncol 2009;5:1129-43
8. Mani SA, Guo W, Liao MJ, et al. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-15
9. Kang Y, Massagué J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004;118:277-9
10. Sánchez-Tilló E, Liu Y, de Barrios O, et al. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol Life Sci 2012;69:3429-56
11. Iwatsuki M, Mimori K, Yokobori T, et al. Epithelialmesenchymal transition in cancer development and its clinical significance. Cancer Sci 2010;101:293-9
12. Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell 2006;127:679-95
13. Puisieux A, Brabletz T, Caramel J. Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol 2014;16:488-94
14. Lee TK, Poon RT, Yuen AP, et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 2006;12:5369-76
15. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004;117:927-39
16. Wushou A, Hou J, Zhao YJ, et al. Twist-1 up-regulation in carcinoma correlates to poor survival. Int J Mol Sci 2014;15:21621-30
17. Miura N, Yano T, Shoji F, et al. Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression. Anticancer Res 2009;29:4099-106
18. Hung JJ, Yang MH, Hsu HS, et al. Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax 2009;64:1082-9
19. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007;9:166-80
20. Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into metaanalysis. Trials 2007;8:16
21. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58
22. Hui L, Zhang S, Dong X, et al. Prognostic significance of twist and N-cadherin expression in NSCLC. PLoS One 2013;8:e62171
23. Shi Y, Wu H, Zhang M, et al. Expression of the epithelialmesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma. Diagn Pathol 2013;8:89
24. Jiang W, Pang XG, Wang Q, et al. Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-smallcell lung cancer after curative resection. Clin Lung Cancer 2012;13:280-7
25. Pallier K, Cessot A, Côté JF, et al. TWIST1 a new determinant of epithelial to mesenchymal transition in EGFR mutated lung adenocarcinoma. PLoS One 2012;7:e29954
26. Wushou A, Pan HY, Liu W, et al. Correlation of increased twist with lymph node metastasis in patients with oral squamous cell carcinoma. J Oral Maxillofac Surg 2012;70:1473-9
27. Kyo S, Sakaguchi J, Ohno S, et al. High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Hum Pathol 2006;37:431-8
28. Lee KW, Kim JH, Han S, et al. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition. Ann Surg Oncol 2012;19:326-35
29. Beck B, Lapouge G, Rorive S, et al. Different levels of Twist1 regulate skin tumor initiation, stemness, and progression. Cell Stem Cell 2015;16:67-79.